vs

Side-by-side financial comparison of Forestar Group Inc. (FOR) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Forestar Group Inc. is the larger business by last-quarter revenue ($273.0M vs $225.6M, roughly 1.2× Organogenesis Holdings Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 5.6%, a 13.7% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 9.0%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $-157.1M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs -9.6%).

Forestar Group Inc. is a residential lot development company based in Arlington, Texas. The company has operations in 51 markets in 21 states and delivered 11,518 residential lots during the twelve-month period ended December 31, 2020. The company is publicly traded on the New York Stock Exchange and in October 2017 became a majority-owned subsidiary of D.R. Horton, Inc., the largest homebuilder by volume in the United States since 2002. The company primarily acquires entitled real estate and...

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

FOR vs ORGO — Head-to-Head

Bigger by revenue
FOR
FOR
1.2× larger
FOR
$273.0M
$225.6M
ORGO
Growing faster (revenue YoY)
ORGO
ORGO
+69.1% gap
ORGO
78.1%
9.0%
FOR
Higher net margin
ORGO
ORGO
13.7% more per $
ORGO
19.4%
5.6%
FOR
More free cash flow
ORGO
ORGO
$191.9M more FCF
ORGO
$34.8M
$-157.1M
FOR
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
-9.6%
FOR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FOR
FOR
ORGO
ORGO
Revenue
$273.0M
$225.6M
Net Profit
$15.4M
$43.7M
Gross Margin
20.1%
Operating Margin
7.6%
28.1%
Net Margin
5.6%
19.4%
Revenue YoY
9.0%
78.1%
Net Profit YoY
-6.7%
469.5%
EPS (diluted)
$0.30
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FOR
FOR
ORGO
ORGO
Q4 25
$273.0M
$225.6M
Q3 25
$670.5M
$150.9M
Q2 25
$390.5M
$101.0M
Q1 25
$351.0M
$86.7M
Q4 24
$250.4M
$126.7M
Q3 24
$551.3M
$115.2M
Q2 24
$318.4M
$130.2M
Q1 24
$333.8M
$110.0M
Net Profit
FOR
FOR
ORGO
ORGO
Q4 25
$15.4M
$43.7M
Q3 25
$86.9M
$21.6M
Q2 25
$32.9M
$-9.4M
Q1 25
$31.6M
$-18.8M
Q4 24
$16.5M
$7.7M
Q3 24
$81.5M
$12.3M
Q2 24
$38.7M
$-17.0M
Q1 24
$45.0M
$-2.1M
Gross Margin
FOR
FOR
ORGO
ORGO
Q4 25
20.1%
Q3 25
22.3%
Q2 25
20.4%
Q1 25
22.6%
72.6%
Q4 24
22.0%
75.5%
Q3 24
23.9%
76.7%
Q2 24
22.5%
77.6%
Q1 24
24.9%
73.9%
Operating Margin
FOR
FOR
ORGO
ORGO
Q4 25
7.6%
28.1%
Q3 25
16.9%
13.7%
Q2 25
11.2%
-12.5%
Q1 25
11.6%
-30.9%
Q4 24
8.7%
8.1%
Q3 24
19.7%
5.4%
Q2 24
16.2%
-10.7%
Q1 24
17.6%
-3.5%
Net Margin
FOR
FOR
ORGO
ORGO
Q4 25
5.6%
19.4%
Q3 25
13.0%
14.3%
Q2 25
8.4%
-9.3%
Q1 25
9.0%
-21.7%
Q4 24
6.6%
6.1%
Q3 24
14.8%
10.7%
Q2 24
12.2%
-13.1%
Q1 24
13.5%
-1.9%
EPS (diluted)
FOR
FOR
ORGO
ORGO
Q4 25
$0.30
$0.31
Q3 25
$1.70
$0.11
Q2 25
$0.65
$-0.10
Q1 25
$0.62
$-0.17
Q4 24
$0.32
$0.05
Q3 24
$1.59
$0.09
Q2 24
$0.76
$-0.13
Q1 24
$0.89
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FOR
FOR
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$211.7M
$93.7M
Total DebtLower is stronger
$793.2M
Stockholders' EquityBook value
$1.8B
$300.1M
Total Assets
$3.2B
$598.7M
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FOR
FOR
ORGO
ORGO
Q4 25
$211.7M
$93.7M
Q3 25
$379.2M
$63.7M
Q2 25
$189.2M
$73.1M
Q1 25
$174.3M
$110.0M
Q4 24
$132.0M
$135.6M
Q3 24
$481.2M
$94.3M
Q2 24
$359.2M
$89.9M
Q1 24
$416.2M
$88.6M
Total Debt
FOR
FOR
ORGO
ORGO
Q4 25
$793.2M
Q3 25
$802.7M
Q2 25
$872.8M
Q1 25
$872.5M
Q4 24
$806.8M
Q3 24
$706.4M
$62.3M
Q2 24
$706.1M
$63.8M
Q1 24
$705.7M
$65.2M
Stockholders' Equity
FOR
FOR
ORGO
ORGO
Q4 25
$1.8B
$300.1M
Q3 25
$1.8B
$255.1M
Q2 25
$1.7B
$233.2M
Q1 25
$1.6B
$242.9M
Q4 24
$1.6B
$262.9M
Q3 24
$1.6B
$278.5M
Q2 24
$1.5B
$263.5M
Q1 24
$1.5B
$278.0M
Total Assets
FOR
FOR
ORGO
ORGO
Q4 25
$3.2B
$598.7M
Q3 25
$3.1B
$509.8M
Q2 25
$3.1B
$461.1M
Q1 25
$3.0B
$467.4M
Q4 24
$3.0B
$497.9M
Q3 24
$2.8B
$446.3M
Q2 24
$2.7B
$443.2M
Q1 24
$2.6B
$458.5M
Debt / Equity
FOR
FOR
ORGO
ORGO
Q4 25
0.44×
Q3 25
0.45×
Q2 25
0.52×
Q1 25
0.53×
Q4 24
0.50×
Q3 24
0.44×
0.22×
Q2 24
0.47×
0.24×
Q1 24
0.48×
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FOR
FOR
ORGO
ORGO
Operating Cash FlowLast quarter
$-157.0M
$39.4M
Free Cash FlowOCF − Capex
$-157.1M
$34.8M
FCF MarginFCF / Revenue
-57.5%
15.4%
Capex IntensityCapex / Revenue
0.0%
2.1%
Cash ConversionOCF / Net Profit
-10.19×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$93.0M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FOR
FOR
ORGO
ORGO
Q4 25
$-157.0M
$39.4M
Q3 25
$256.3M
$3.1M
Q2 25
$15.8M
$-32.9M
Q1 25
$-19.8M
$-19.9M
Q4 24
$-450.0M
$10.9M
Q3 24
$119.2M
$8.7M
Q2 24
$-61.7M
$4.7M
Q1 24
$-59.2M
$-10.2M
Free Cash Flow
FOR
FOR
ORGO
ORGO
Q4 25
$-157.1M
$34.8M
Q3 25
$255.6M
$844.0K
Q2 25
$15.0M
$-36.5M
Q1 25
$-20.5M
$-23.6M
Q4 24
$7.6M
Q3 24
$118.4M
$6.1M
Q2 24
$-62.3M
$2.9M
Q1 24
$-59.8M
$-12.4M
FCF Margin
FOR
FOR
ORGO
ORGO
Q4 25
-57.5%
15.4%
Q3 25
38.1%
0.6%
Q2 25
3.8%
-36.1%
Q1 25
-5.8%
-27.2%
Q4 24
6.0%
Q3 24
21.5%
5.3%
Q2 24
-19.6%
2.2%
Q1 24
-17.9%
-11.3%
Capex Intensity
FOR
FOR
ORGO
ORGO
Q4 25
0.0%
2.1%
Q3 25
0.1%
1.5%
Q2 25
0.2%
3.6%
Q1 25
0.2%
4.2%
Q4 24
0.0%
2.7%
Q3 24
0.1%
2.2%
Q2 24
0.2%
1.4%
Q1 24
0.2%
2.0%
Cash Conversion
FOR
FOR
ORGO
ORGO
Q4 25
-10.19×
0.90×
Q3 25
2.95×
0.14×
Q2 25
0.48×
Q1 25
-0.63×
Q4 24
-27.27×
1.43×
Q3 24
1.46×
0.71×
Q2 24
-1.59×
Q1 24
-1.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FOR
FOR

D.R.Horton Inc.$183.8M67%
Other$89.2M33%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons